Literature DB >> 7748460

Selective cortical decrease of high-affinity choline uptake carrier in Alzheimer's disease: an autoradiographic study using 3H-hemicholinium-3.

R Rodríguez-Puertas1, A Pazos, J J Zarranz, J Pascual.   

Abstract

3H-hemicholinium-3 (3H-HC-3) binding, a marker of the presynaptic high-affinity choline uptake carrier (HACU), was measured by autoradiography in several brain regions of 17 Alzheimer's disease (AD) patients and of 11 matched controls. A significant decrease in the density of 3H-HC-3 binding sites was found in entorhinal cortex, hippocampus and layers I-III of the frontal cortex. By contrast, in the caudate-putamen the number of 3H-HC-3 binding sites in AD cases was comparable to that of control striata. These data concur with previous results using classical presynaptic markers and reflect the loss in the activity of HACU, and, hence, in the synthesis of acetylcholine, that selectively occurs in cortical areas of AD brains due to the degeneration of presynaptic cholinergic terminals arising from the basal forebrain. However, the relatively low mean reduction in HACU in cortical areas (-40%), together with the apparent indemnity of this marker in certain severely demented AD cases, suggest that AD dementia cannot be explained simply by the loss of presynaptic terminals originating in the basal forebrain. These data seem to be a good explanation for the poor response to cholinergic replacement in AD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7748460     DOI: 10.1007/BF02260937

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  9 in total

1.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  MKC-231, a choline uptake enhancer: (2) Effect on synthesis and release of acetylcholine in AF64A-treated rats.

Authors:  Ken Takashina; Tomoko Bessho; Reiko Mori; Junichi Eguchi; Ken-Ichi Saito
Journal:  J Neural Transm (Vienna)       Date:  2008-04-30       Impact factor: 3.575

3.  MKC-231, a choline uptake enhancer: (3) Mode of action of MKC-231 in the enhancement of high-affinity choline uptake.

Authors:  Ken Takashina; Tomoko Bessho; Reiko Mori; Kunji Kawai; Junichi Eguchi; Ken-Ichi Saito
Journal:  J Neural Transm (Vienna)       Date:  2008-05-07       Impact factor: 3.575

4.  Insulin Regulates the Activity of the High-Affinity Choline Transporter CHT.

Authors:  Katherine J Fishwick; R Jane Rylett
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

5.  Rejuvenating procholinergic treatments for cognition enhancement in AD: current challenges and future prospects.

Authors:  Brittney Yegla; Vinay Parikh
Journal:  Front Syst Neurosci       Date:  2015-01-28

6.  Modulatory role of simvastatin against aluminium chloride-induced behavioural and biochemical changes in rats.

Authors:  Madhavan Nampoothiri; Jessy John; Nitesh Kumar; Jayesh Mudgal; Gopalan Kutty Nampurath; Mallikarjuna Rao Chamallamudi
Journal:  Behav Neurol       Date:  2015-01-31       Impact factor: 3.342

7.  Blockage of High-Affinity Choline Transporter Increases Visceral Hypersensitivity in Rats with Chronic Stress.

Authors:  Chen Zhao; Mengjuan Lin; Yasi Pan; Baoping Yu
Journal:  Gastroenterol Res Pract       Date:  2018-04-04       Impact factor: 2.260

8.  Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease.

Authors:  Alberto Llorente-Ovejero; Jonatan Martínez-Gardeazabal; Marta Moreno-Rodríguez; Laura Lombardero; Estíbaliz González de San Román; Iván Manuel; María Teresa Giralt; Rafael Rodríguez-Puertas
Journal:  ACS Chem Neurosci       Date:  2021-05-26       Impact factor: 5.780

9.  A Rat Model of Alzheimer's Disease Based on Abeta42 and Pro-oxidative Substances Exhibits Cognitive Deficit and Alterations in Glutamatergic and Cholinergic Neurotransmitter Systems.

Authors:  Tomas Petrasek; Martina Skurlova; Kristyna Maleninska; Iveta Vojtechova; Zdena Kristofikova; Hana Matuskova; Jana Sirova; Karel Vales; Daniela Ripova; Ales Stuchlik
Journal:  Front Aging Neurosci       Date:  2016-04-20       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.